| Walter A. Kukull | |
|---|---|
| Photo placeholder | |
| Affiliations | University of Washington |
| Country | USA |
| H-index | 100 |
| Research Focus | Alzheimer's Disease |
| Mechanisms | Epidemiology |
Walter A. Kukull is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Kukull has developed research programs that bridge basic neuroscience, translational biomarker work, and clinical interpretation. Across appointments at University of Washington, their group has helped define how mechanistic discoveries are converted into robust disease models and clinically actionable hypotheses.
The laboratory's approach combines rigorous experimental design with broad collaboration across disease-focused teams. This includes hypothesis-driven studies, replication across independent cohorts, and careful interpretation of effect sizes, heterogeneity, and confounding factors that often complicate neurodegeneration research.
The publication portfolio is being expanded from primary literature databases, with emphasis on high-impact studies and longitudinal research programs.
Their program contributes to translational and mechanistic work in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--.
The lab emphasizes Epidemiology to connect molecular findings with patient outcomes.
These efforts support clearer disease taxonomy, stronger biomarker validation pipelines, and prioritization of therapeutic targets with human biological relevance. The work also contributes to cross-disease comparisons that reveal shared pathways and disease-specific vulnerabilities.
Current priorities in Kukull's research ecosystem include improving reproducibility across cohorts, integrating multi-omic and longitudinal clinical datasets, and clarifying which biological signals are most predictive of near-term progression and treatment response. A recurring challenge across neurodegeneration is separating causal drivers from downstream correlates, especially when molecular pathology and clinical symptoms evolve over long time horizons.
Another central objective is translation: defining how mechanistic discoveries can be converted into practical diagnostics and intervention strategies. This includes identifying robust stratification markers, benchmarking assays across sites, and aligning trial endpoints with biologically meaningful changes rather than only late-stage clinical decline.
McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). DOI
Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's disease." Molecular psychiatry (2025). DOI
Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer Disease." JAMA neurology (2025). DOI
Lorenz A et al.. "The effect of Alzheimer's disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). DOI
Godrich D et al.. "Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population." Alzheimers Dement (2022). DOI
Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's disease." Alzheimers Dement (2022). DOI
Krysinska K et al.. "Dementia registries around the globe and their applications: A systematic review." Alzheimers Dement (2017). DOI
Neu SC et al.. "Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis." JAMA neurology (2017). DOI
McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). DOI: 10.1212/WNL.0000000000004058 PubMed: 28592453
Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's disease." Molecular psychiatry (2025). DOI: 10.1038/s41380-024-02838-5 PubMed: 39633006
Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer Disease." JAMA neurology (2025). DOI: 10.1001/jamaneurol.2025.1601 PubMed: 40513084
Lorenz A et al.. "The effect of Alzheimer's disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). DOI: 10.1002/alz.70130 PubMed: 40219815
Godrich D et al.. "Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population." Alzheimers Dement (2022). DOI: 10.1002/alz.12516 PubMed: 35142102
Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's disease." Alzheimers Dement (2022). DOI: 10.1002/alz.12567 PubMed: 35258170
Krysinska K et al.. "Dementia registries around the globe and their applications: A systematic review." Alzheimers Dement (2017). DOI: 10.1016/j.jalz.2017.04.005 PubMed: 28576507
Neu SC et al.. "Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis." JAMA neurology (2017). DOI: 10.1001/jamaneurol.2017.2188 PubMed: 28846757
Collaborator network pending enrichment.
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). DOI)
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). DOI)
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). DOI)
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). DOI)
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). DOI)
[Hohman TJ et al.. "Sex-Specific Association of [Apolipoprotein E[/entities/[apoe[/entities/[apoe[/entities/[apoe--TEMP--/entities)--FIX-- With Cerebrospinal Fluid Levels of [Tau[/entities/[tau-protein[/entities/[tau-protein[/entities/[tau-protein--TEMP--/entities)--FIX--." JAMA neurology (2018). DOI)
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). DOI)
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). DOI)
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). [DOI: 10.1212/WNL.0000000000004058]https://doi.org/10.1212/WNL.0000000000004058) PubMed: 28592453
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). [DOI: 10.1001/jamaneurol.2025.1601]https://doi.org/10.1001/jamaneurol.2025.1601) PubMed: 40513084
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). [DOI: 10.1038/s41380-024-02838-5]https://doi.org/10.1038/s41380-024-02838-5) PubMed: 39633006
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). [DOI: 10.1002/alz.12567]https://doi.org/10.1002/alz.12567) PubMed: 35258170
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). [DOI: 10.1007/s00401-018-1881-4]https://doi.org/10.1007/s00401-018-1881-4) PubMed: 29967939
[Hohman TJ et al.. "Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau." JAMA neurology (2018). [DOI: 10.1001/jamaneurol.2018.0821]https://doi.org/10.1001/jamaneurol.2018.0821) PubMed: 29801024
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). [DOI: 10.1093/brain/awz206]https://doi.org/10.1093/brain/awz206) PubMed: 31497858
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). [DOI: 10.1002/alz.70130]https://doi.org/10.1002/alz.70130) PubMed: 40219815
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). DOI)
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). DOI)
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). DOI)
[Hohman TJ et al.. "Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau." JAMA neurology (2018). DOI)
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). DOI)
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). DOI)
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). DOI)
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). DOI)
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). [DOI: 10.1212/WNL.0000000000004058]https://doi.org/10.1212/WNL.0000000000004058) PubMed: 28592453
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). [DOI: 10.1001/jamaneurol.2025.1601]https://doi.org/10.1001/jamaneurol.2025.1601) PubMed: 40513084
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). [DOI: 10.1038/s41380-024-02838-5]https://doi.org/10.1038/s41380-024-02838-5) PubMed: 39633006
[Hohman TJ et al.. "Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau." JAMA neurology (2018). [DOI: 10.1001/jamaneurol.2018.0821]https://doi.org/10.1001/jamaneurol.2018.0821) PubMed: 29801024
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). [DOI: 10.1007/s00401-018-1881-4]https://doi.org/10.1007/s00401-018-1881-4) PubMed: 29967939
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). [DOI: 10.1002/alz.12567]https://doi.org/10.1002/alz.12567) PubMed: 35258170
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). [DOI: 10.1093/brain/awz206]https://doi.org/10.1093/brain/awz206) PubMed: 31497858
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). [DOI: 10.1002/alz.70130]https://doi.org/10.1002/alz.70130) PubMed: 40219815
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). DOI)
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). DOI)
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). DOI)
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). DOI)
[Hohman TJ et al.. "Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau." JAMA neurology (2018). DOI)
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). DOI)
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). DOI)
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). DOI)
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). [DOI: 10.1212/WNL.0000000000004058]https://doi.org/10.1212/WNL.0000000000004058) PubMed: 28592453
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). [DOI: 10.1001/jamaneurol.2025.1601]https://doi.org/10.1001/jamaneurol.2025.1601) PubMed: 40513084
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). [DOI: 10.1038/s41380-024-02838-5]https://doi.org/10.1038/s41380-024-02838-5) PubMed: 39633006
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). [DOI: 10.1002/alz.12567]https://doi.org/10.1002/alz.12567) PubMed: 35258170
[Hohman TJ et al.. "Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau." JAMA neurology (2018). [DOI: 10.1001/jamaneurol.2018.0821]https://doi.org/10.1001/jamaneurol.2018.0821) PubMed: 29801024
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). [DOI: 10.1007/s00401-018-1881-4]https://doi.org/10.1007/s00401-018-1881-4) PubMed: 29967939
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). [DOI: 10.1093/brain/awz206]https://doi.org/10.1093/brain/awz206) PubMed: 31497858
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). [DOI: 10.1002/alz.70130]https://doi.org/10.1002/alz.70130) PubMed: 40219815
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). DOI)
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). DOI)
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). DOI)
[Hohman TJ et al.. "Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau." JAMA neurology (2018). DOI)
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). DOI)
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). DOI)
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). DOI)
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). DOI)
[McKeith IG et al.. "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium." Neurology (2017). [DOI: 10.1212/WNL.0000000000004058]https://doi.org/10.1212/WNL.0000000000004058) PubMed: 28592453
[Peter C et al.. "White Matter Abnormalities and Cognition in Aging and Alzheimer's Disease." JAMA neurology (2025). [DOI: 10.1001/jamaneurol.2025.1601]https://doi.org/10.1001/jamaneurol.2025.1601) PubMed: 40513084
[Le Borgne J et al.. "X-chromosome-wide association study for Alzheimer's Disease." Molecular psychiatry (2025). [DOI: 10.1038/s41380-024-02838-5]https://doi.org/10.1038/s41380-024-02838-5) PubMed: 39633006
[Hohman TJ et al.. "Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau." JAMA neurology (2018). [DOI: 10.1001/jamaneurol.2018.0821]https://doi.org/10.1001/jamaneurol.2018.0821) PubMed: 29801024
[Deming Y et al.. "Sex-specific genetic predictors of Alzheimer's Disease biomarkers." Acta neuropathologica (2018). [DOI: 10.1007/s00401-018-1881-4]https://doi.org/10.1007/s00401-018-1881-4) PubMed: 29967939
[Vardarajan BN et al.. "Progranulin mutations in clinical and neuropathological Alzheimer's Disease." Alzheimers Dement (2022). [DOI: 10.1002/alz.12567]https://doi.org/10.1002/alz.12567) PubMed: 35258170
[Dumitrescu L et al.. "Sex differences in the genetic predictors of Alzheimer's pathology." Brain : a journal of neurology (2019). [DOI: 10.1093/brain/awz206]https://doi.org/10.1093/brain/awz206) PubMed: 31497858
[Lorenz A et al.. "The effect of Alzheimer's Disease genetic factors on limbic white matter microstructure." Alzheimers Dement (2025). [DOI: 10.1002/alz.70130]https://doi.org/10.1002/alz.70130) PubMed: 40219815
Recent publications involving [Walter Kukull[/researchers/[walter-kukull[/researchers/[walter-kukull[/researchers/[walter-kukull--TEMP--/researchers)--FIX-- advance [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX-- genetics by clarifying [APOE[/entities/apoe-linked decline modifiers, resilience phenotypes, and polygenic contributions across onset groups.[/entities/apoe-linked decline modifiers, resilience phenotypes, and polygenic contributions across onset groups.[/entities/apoe-linked decline modifiers, resilience phenotypes, and polygenic contributions across onset groups.[/entities//entities/apoe-linked decline modifiers, resilience phenotypes, and polygenic contributions across onset groups.[/entities//entities//entities/apoe-linked decline modifiers, resilience phenotypes, and polygenic contributions across onset groups.[/entities//entities//entities//entities/apoe-linked decline modifiers, resilience phenotypes, and polygenic contributions across onset groups.](/entities//entities//entities//entities/apoe-linked decline modifiers, resilience phenotypes, and polygenic contributions across onset groups.)
The study of Walter A. Kukull has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.